GO Term | Evidence Code | PMID |
---|---|---|
negative regulation of membrane potential | ||
negative regulation of heterotypic cell-cell adhesion | ||
acute-phase response | ||
response to glucocorticoid | ||
insulin secretion |
GO Term | Evidence Code | PMID |
---|---|---|
extracellular space | ||
extracellular region | ||
centrosome | ||
nucleoplasm | ||
cytosol |
GO Term | Evidence Code | PMID |
---|---|---|
interleukin-1, type I receptor binding | ||
interleukin-1 receptor antagonist activity | ||
interleukin-1 type I receptor antagonist activity | ||
interleukin-1, type II receptor binding | ||
interleukin-1 type II receptor antagonist activity |
DO ID | Disease Name | Source |
---|---|---|
DOID:898 | autosomal dominant polycystic kidney disease | |
DOID:9074 | systemic lupus erythematosus | |
DOID:9352 | type 2 diabetes mellitus | |
DOID:9498 | pulmonary eosinophilia | |
DOID:9538 | multiple myeloma | |
DOID:9588 | encephalitis | |
DOID:9744 | type 1 diabetes mellitus | |
DOID:986 | alopecia areata | |
DOID:9938 | dacryocystitis | |
DOID:9970 | obesity |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.1.1
Last updated: February 17, 2025